Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
---|
05/26/2005 | US20050112671 Analyzing polymers; such as Dna, Rna; generating signals; using probe capable of hybridization |
05/26/2005 | US20050112636 Detect sensitivity; multiple neotide sequences |
05/26/2005 | US20050112634 High density sequence detection methods and apparatus |
05/26/2005 | US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
05/26/2005 | US20050112590 Spectrometric analysis ; splitting compound; measurement signals; calibration |
05/26/2005 | US20050112562 Inhibition of retroviral replication through modulation of the host cell ubiquitylation |
05/26/2005 | US20050112555 Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof |
05/26/2005 | US20050112554 An insertion/a deletion early-stage-specific molecular marker, a single nucleotide variation (SNV) early-stage-specific molecular marker; SARS-CoV (coronaviruses) strains obtained from the earliest infected patients in a SARS outbreak, uses of these data for diagnosis, drug/vaccine development |
05/26/2005 | US20050112173 In vivo synthesis of connective tissues |
05/26/2005 | US20050112130 Enhanced B cell cytotoxicity of CDIM binding antibody |
05/26/2005 | US20050112122 Generation of hematopoietic chimerism and induction of central tolerance |
05/26/2005 | CA2550274A1 Real time electronic cell sensing systems and applications for cell-based assays |
05/26/2005 | CA2548080A1 Porcine isogloboside 3 synthase protein, cdna, genomic organization, and regulatory region |
05/26/2005 | CA2545356A1 Nucleic acid detection method having increased sensitivity |
05/26/2005 | CA2545252A1 Improved methods for detecting and measuring specific nucleic acid sequences |
05/26/2005 | CA2544923A1 Method and antisense compound for potentiating anti-cancer agents |
05/26/2005 | CA2544347A1 Motoneuronotrophic factor gene sequences |
05/26/2005 | CA2544253A1 Novel sequences encoding hepatitis c virus glycoproteins |
05/26/2005 | CA2544239A1 Methods for the production of apolipoproteins in transgenic plants |
05/26/2005 | CA2542574A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
05/26/2005 | CA2542564A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
05/26/2005 | CA2541216A1 .delta.12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
05/26/2005 | CA2536645A1 Long-wavelength fps |
05/25/2005 | EP1532271A2 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
05/25/2005 | CN1618972A Regulation of quinolate phosphoribosyl transferase expression |
05/24/2005 | CA2037607C Humanised antibodies |
05/19/2005 | WO2005045001A2 Insulin-producing cells derived from stem cells |
05/19/2005 | WO2005045000A2 Estrogen receptor gene variation and disease |
05/19/2005 | WO2005044999A2 Treatment with immunoregulatory t cells |
05/19/2005 | WO2005044998A2 Enhanced b cell cytotoxicity of cdim binding antibody |
05/19/2005 | WO2005044997A2 Identification of novel targets for radio sensitization using a genomic-based radiation sensitivity classifier |
05/19/2005 | WO2005044996A2 Chimeric receptors with 4-1bb stimulatory signaling domain |
05/19/2005 | WO2005044995A2 Uses of human peptide deformylase |
05/19/2005 | WO2005044994A2 High temperature and alkaline stable catalase |
05/19/2005 | WO2005044993A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
05/19/2005 | WO2005044992A2 Fusion initiation region in rna virus envelope proteins |
05/19/2005 | WO2005044991A2 Compositions and methods of use for a fibroblast growth factor |
05/19/2005 | WO2005044990A2 Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
05/19/2005 | WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same |
05/19/2005 | WO2005044988A2 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
05/19/2005 | WO2005044987A2 Tocopherol associated protein and uses thereof |
05/19/2005 | WO2005044986A2 Methods and compositions for detection of segmented negative strand rna viruses |
05/19/2005 | WO2005044984A2 Modulators of the abc transporter family and methods for their use |
05/19/2005 | WO2005044982A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
05/19/2005 | WO2005044980A2 Zap protein and related compositions and methods |
05/19/2005 | WO2005044979A2 Glycosylation enzymes and systems and methods of making and using them |
05/19/2005 | WO2005044978A2 Methods of treating, preventing and inhibiting cancer metastasis and tumor formation |
05/19/2005 | WO2005044977A2 Compositions, splice variants and methods relating to lung specific genes and proteins |
05/19/2005 | WO2005044976A2 Oligomeric compounds for use in gene modulation |
05/19/2005 | WO2005044975A2 Genes encoding carotenoid compounds |
05/19/2005 | WO2005044974A2 Cell death-related nucleases and their uses |
05/19/2005 | WO2005044973A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL |
05/19/2005 | WO2005033289A3 Transfection reagents |
05/19/2005 | WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
05/19/2005 | WO2005021720A3 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
05/19/2005 | WO2005021713A8 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
05/19/2005 | WO2005017093A8 Polypeptides of streptococcus pyogenes |
05/19/2005 | WO2005014784A3 System for molecular imaging |
05/19/2005 | WO2005007802A3 Fibrous composite for tissue engineering |
05/19/2005 | WO2004106490A3 NOVEL METHODS FOR FINDING MUTATIONS CAUSED BY THE INSERTION OF REPETEAD DNAs |
05/19/2005 | WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
05/19/2005 | WO2004083402A3 Spleen necrosis predictive genes |
05/19/2005 | WO2004078924A3 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
05/19/2005 | WO2004076634A3 Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
05/19/2005 | WO2004044141A3 Conjugated oligomeric compounds and their use in gene modulation |
05/19/2005 | WO2004031351A3 Microarrays having multiple oligonucleotides in single array features |
05/19/2005 | US20050108783 Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region |
05/19/2005 | US20050107605 Novel beta-lactams methods for the preparation of taxanes, and sidechain-bearing taxanes |
05/19/2005 | US20050107325 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
05/19/2005 | US20050106717 Cell culture methods and devices utilizing gas permeable materials |
05/19/2005 | US20050106693 Metabolically engineered bacterial strains having enhanced 2-keto-D-gluconate accumulation |
05/19/2005 | US20050106647 Antibodies with increased affinities for anthrax antigens |
05/19/2005 | US20050106630 Building blocks for artificial receptors |
05/19/2005 | US20050106596 Nucleic acid analysis methods conducted in small reaction volumes |
05/19/2005 | US20050106594 In vitro selection of aptamer beacons |
05/19/2005 | US20050106222 Genetic engineering; gene expression; polypeptides |
05/19/2005 | US20050106151 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax |
05/19/2005 | US20050106133 Containing lactobacillus; storage stability |
05/19/2005 | US20050106124 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
05/19/2005 | CA2548538A1 Compositions and methods of use for a fibroblast growth factor |
05/19/2005 | CA2544848A1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins |
05/19/2005 | CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
05/19/2005 | CA2543956A1 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
05/19/2005 | CA2543442A1 High temperature and alkaline stable catalase |
05/19/2005 | CA2542886A1 Enhanced b cell cytotoxicity of cdim binding antibody |
05/19/2005 | CA2537759A1 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
05/19/2005 | CA2528574A1 Genes encoding carotenoid compounds |
05/18/2005 | EP1222256B1 Method to improve the stability and broaden the ph range of family g/11 xylanases |
05/12/2005 | WO2005042727A2 Methods of organ regeneration |
05/12/2005 | WO2005042725A2 Liver cancer biomarkers |
05/12/2005 | WO2005042724A2 An apparatus and method for growing bacteria, for use in wastewater treatment, biological pest management, bioremediation of soil and wastes, and other applications |
05/12/2005 | WO2005042722A2 Materials and methods for improved sweet corn |
05/12/2005 | WO2005042721A2 A method for altering the gender ratio of offspring in mammals by manipulation of spermatozoa |
05/12/2005 | WO2005042720A2 Kahalalide-producing bacteria |
05/12/2005 | WO2005042719A2 Methods for treating and preventing ischemia-reperfusion injury using rna interfering agents |
05/12/2005 | WO2005042718A2 Compositions and methods for treating, preventing, reversing and inhibiting pain |
05/12/2005 | WO2005042717A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
05/12/2005 | WO2005042716A2 Nucleic acid binding oligonucleotides |
05/12/2005 | WO2005042715A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels |
05/12/2005 | WO2005042714A2 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |